1. Home
  2. NGVC vs CTMX Comparison

NGVC vs CTMX Comparison

Compare NGVC & CTMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Natural Grocers by Vitamin Cottage Inc.

NGVC

Natural Grocers by Vitamin Cottage Inc.

HOLD

Current Price

$31.62

Market Cap

757.8M

ML Signal

HOLD

Logo CytomX Therapeutics Inc.

CTMX

CytomX Therapeutics Inc.

HOLD

Current Price

$3.31

Market Cap

642.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NGVC
CTMX
Founded
1955
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Food Chains
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
757.8M
642.2M
IPO Year
2012
2015

Fundamental Metrics

Financial Performance
Metric
NGVC
CTMX
Price
$31.62
$3.31
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
10
Target Price
$36.00
$12.10
AVG Volume (30 Days)
95.7K
3.9M
Earning Date
05-07-2026
05-08-2026
Dividend Yield
2.16%
N/A
EPS Growth
36.05
N/A
EPS
1.07
N/A
Revenue
N/A
$76,201,000.00
Revenue This Year
$7.08
N/A
Revenue Next Year
$6.04
$7.61
P/E Ratio
$29.58
$22.58
Revenue Growth
N/A
N/A
52 Week Low
$23.47
$1.72
52 Week High
$45.98
$8.21

Technical Indicators

Market Signals
Indicator
NGVC
CTMX
Relative Strength Index (RSI) 51.69 40.78
Support Level $30.36 $2.82
Resistance Level $34.24 $3.94
Average True Range (ATR) 1.21 0.19
MACD -0.32 -0.05
Stochastic Oscillator 54.36 14.02

Price Performance

Historical Comparison
NGVC
CTMX

About NGVC Natural Grocers by Vitamin Cottage Inc.

Natural Grocers by Vitamin Cottage Inc operates natural and organic grocery and dietary supplement stores. It offers the following product categories: natural and organic food, dietary supplements, natural body care, household, pet care products, books, and handouts. The Company has a single reporting segment, natural and organic retail stores, through which business is conducted. The company generates the majority of its revenue from grocery products and dietary supplements, and the rest from other products.

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

Share on Social Networks: